Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

257318 items
2:39 PM, Jun 23, 2018  |  BC Extra | Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

As a busy week for IPO pricings came to a close, several more companies filed for NASDAQ listings late Friday, further stocking an IPO pipeline of companies likely to seek liquidity during a tight calendar...
5:55 PM, Jun 22, 2018  |  BioCentury | Emerging Company Profile

Cerevance’s human element

Cerevance Inc. plans to treat neurological diseases by rebalancing disrupted neuronal circuits. The company is identifying circuit-specific neurological targets via its NETSeq RNA profiling platform, and thinks its ability to start with human tissue will...
5:51 PM, Jun 22, 2018  |  BioCentury | Strategy

Gawande’s Cheesecake Factory

Details about the healthcare organization Atul Gawande will run for Amazon.com Inc., Berkshire Hathaway Inc. and J. P. Morgan Chase & Co. are scarce -- basic facts, starting with its name, have not been disclosed....
5:15 PM, Jun 22, 2018  |  BioCentury | Regulation

Emergency preparedness

Borrowing a page from the software industry, FDA Commissioner Scott Gottlieb believes that licensing rather than selling certain antibiotics could help address the crisis of multidrug resistant pathogens. He is hoping to work with CMS...
4:44 PM, Jun 22, 2018  |  BC Extra | Company News

Roche taps gRED’s Sabry as global head of partnering

A newly created global head of partnering role at Roche (SIX:ROG; OTCQX:RHHBY) is set to combine the pharma’s partnering functions for the first time since it completed its acquisition of Genentech Inc. James Sabry, head...
4:16 PM, Jun 22, 2018  |  BC Extra | Company News

FDA cracks down on missing postmarket trial

FDA determined the Perrigo Israel Pharmaceuticals Ltd. unit of Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO) has failed to comply with a postmarketing trial requirement to assess the risk of major cardiovascular events (MACE) associated with...
4:01 PM, Jun 22, 2018  |  BC Extra | Preclinical News

Alzheimer's disease linked to herpesvirus

Researchers from the Icahn School of Medicine at Mount Sinai and colleagues found traces of mild strains of herpesvirus in the brains of patients with Alzheimer's disease, adding evidence to previous theories that some viruses...
3:55 PM, Jun 22, 2018  |  BC Extra | Preclinical News

Blocking LSD1 could activate cancer immune response via HERV

A Harvard Medical School team led by immunology and pathology professor Arlene Sharpe has shown inhibiting lysine-specific demethylase (LSD1; KDM1A) increases human endogenous retrovirus (HERV) transcription to activate an immune response that could help treat...
3:48 PM, Jun 22, 2018  |  BC Extra | Politics & Policy

FDA lays out cancer PRO strategy

FDA staff set out the agency’s thinking and progress in developing a standard approach to assessing patient reported outcomes (PROs) at a workshop Friday to discuss clinical outcome assessments in cancer trials. The joint FDA-American...
3:16 PM, Jun 22, 2018  |  BC Extra | Politics & Policy

House passes sweeping opioid legislation

The House of Representatives passed a broad bipartisan measure Friday to combat the opioid crisis by a vote of 396-14. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities...

Pages